Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid

Journal of Andrology

Volumn 20, Issue 2, 1999, Pages 220-229

  Charlesworth, M Cristine ^a   Young, Charles Y F ^a   Miller, Virginia M ^a   Tindall, Donald J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Azoospermia; Bradykinin; hK1; Prostate specific antigen; PSA; Tissue kallikrein

Indexed keywords

KALLIKREIN;

ARTICLE; BIOASSAY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME IMMUNOASSAY; ENZYME SUBSTRATE COMPLEX; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE; SEMINAL PLASMA; SPERMATOZOON MOTILITY;

AMINO ACID SEQUENCE; BRADYKININ; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOENZYME TECHNIQUES; KALLIKREINS; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PROSTATE; SEMEN; TISSUE KALLIKREINS;

EID: 0032937835     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Barber DA, Miller VM. Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries. Am J Physiol 1997;273:H2325-H2332.
2. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol Rev 1992;44:1-79.
3. Charlesworth MC, Young CY-F, Klee GG, Saedi MS, Mikolajczyk SD, Finlay JA, Tindall DJ. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Urology 1997;49:487-493.
4. Deperthes D, Frenette G, Brillard-Boudet M, Bourgeois L, Gauthier F, Tremblay RR, Dube JY. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesical proteins after ejaculation. J Androl 1996;17:659-665.
5. Deperthes D, Marceau F, Frenette G, Lazure C, Tremblay RR, Dube JY. Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen has none. Biochim Biophys Acta 1997;1343:102-106.
6. Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 1993;16:99-104.
7. Ecke S, Geiger M, Resch I, Jerabek I, Sting L, Maier M, Binder BR. Inhibition of tissue kallikrein be protein C inhibitor. J Biol Chem 1992;267:7048-7052.
8. Espana F, Gilabert J, Estelles A, Romeu A, Aznar J. Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991;64:309-320.
9. Fichtner J, Graves HC, Thatcher K, Yemoto C, Shortliffe LM. Prostate specific antigen releases a kinin-like substance on proteolysis of seminal vesical fluid that stimulates smooth muscle contraction. J Urol 1996;155:738-742.
10. Fink E, Schill WB, Miska BW. Kinin-containing kininogen present in human seminal plasma. Adv Evp Med Biol 1989;247B:30-35.
11. Frenette G, Deperthes D, Tremblay RR, Lazure C, Dube JY. Purification of enzymatically active kallikrein hK2 from human seminal plasma. Biochim Biophys Acta 1997;1334:109-115.
12. Grauer LS, Charlesworth MC, Saedi MS, Finlay JA, Liu RS, Kuus-Reichel K, Tindall DJ. Identification of human glandular kallikrein hK2 from LNCaP cells. J Androl 1996;17:353-359.
13. Maeda H, Akaike T, Wu J, Noguchi Y, Sakata Y. Bradykinin and nitric oxide in infectious disease and cancer. Immunopharmacology 1996; 33:222-230.
14. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 1994;45:729-744.
15. Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Human glandular kallikrein, hK2, show arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate 1998;34:44-50.
16. Mori K, Nagasawa S. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. J Biochem 1981;89:1465-1473.
17. Reddigari S, Kaplan AP. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood 1988;71:1334-1340.
18. Saedi M, Cass MJ, Goel AS, Grauer L, Okaneya T, Young C, Tindall DJ. Overexpression of a human prostate-specific glandular kallikrein, hK2 and generation of antibody. Mol Cell Endocrinol 1995;109:237-241.
19. Schedlich LJ, Bennetts BH, Morris BJ. Primary structure of a human glandular kallikrein gene. DNA 1987;6:429-437.
20. Schill WB, Miska W. Possible effects of the kallikrein-kinin system on male reproductive functions. Andrologia 1992;24:69-75.
21. Sensabaugh GF, Blake ET. Seminal plasma protein p30: simplified purification and evidence for identity with prostate specific antigen. J Urol 1990;144:1523-1536.
22. Tremblay RR, Coulombe E, Cloutier S, Brunet C, Deperthes D, Frenette G, Dube JY. Assessment of the trypsin-like human prostatic kallikrein, also known as hK2, in the seminal plasma of infertile men: respective contributions of an ELISA procedure and of Western blotting. J Lab Clin Med 1998;131:330-335.
23. Van Dreden P, Gonzales J, Poirot C. Human seminal fibrinolylic activity: specific determinations of tissue plasminogen activator and urokinase. Andrologia 1991;23:29-33.
24. Yeung CH, Spier B, Cooper TG, Nacke P, Nieschlag E. The effect of bradykinin and the bradykinin antagonist HOE 140 on kinematic parameters of human spermatozoa. Int J Androl 1996;19:143-149.